STOCK TITAN

Privia Health Group (PRVA) DEF 14A Filings

PRVA NASDAQ

Here are the DEF 14A proxy statements from Privia Health Group, Inc. (PRVA) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow PRVA and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PRVA filings page.

Rhea-AI Summary

Privia Health Group, Inc. is asking stockholders to vote at its virtual 2026 annual meeting on May 20, 2026 at 11:00 a.m. Eastern Time. Proposals include electing three Class I directors to terms ending in 2029, an advisory “say‑on‑pay” vote on named executive officer compensation, and ratifying PricewaterhouseCoopers LLP as independent auditor for 2026.

The Board remains classified into three staggered classes and currently has nine directors, most of whom are independent and serve on key committees covering audit, compensation, nominating and governance, and compliance. The company highlights stockholder outreach, strong governance policies such as anti‑hedging and anti‑pledging rules, a robust insider trading policy, and broad ESG, cybersecurity, and talent management initiatives.